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ABSTRACT
Introduction: Shoulder pain is a highly prevalent
condition. Psychological factors could play an
essential role in the prognosis of chronic shoulder
pain (CSP). The aims of the study will be to analyse
the level of association between psychological factors
and pain-disability at baseline and prospectively to
assess their prognostic role; to evaluate the
association of pain catastrophising and kinesiophobia
at baseline and prospectively in the relationship
between pain intensity and disability, or between self-
efficacy and disability in patients with CSP; to explore
the association of self-efficacy at baseline and
prospectively in the relationship between pain
intensity and disability, in comparison with
kinesiophobia and pain catastrophising.
Methods and analysis: The study is a longitudinal,
prospective cohort study with a 12-month follow-up.
It will be conducted in 4 primary-care centres and
one hospital of the province of Malaga, Spain. 307
participants aged between 18 and 70 years suffering
from CSP (3 months or more) will be included.
Primary outcomes will include pain, disability and
self-efficacy, whereas kinesiophobia, pain-related
fear, pain catastrophising, anxiety, depression,
patient expectations of recovery, age, gender,
duration/intensity of symptoms, educational level and
other factors will be predictive measures. Follow-up:
baseline, 3, 6 and 12 months.
Ethics and dissemination: The local ethics
committee (The Costa del Sol Ethics Committee,
Malaga, 28042016) has approved this protocol.
Dissemination will occur through presentations at
National and International conferences and
publications in international peer-reviewed journals.
Trial registration number: NCT02738372; pre-
results
INTRODUCTION
Shoulder pain is the third most common
musculoskeletal condition presenting to phy-
sicians or physiotherapists1 in primary health-
care after low back and neck pain,2 3 being a
signiﬁcant cause of morbidity,4 and
functional disability in both working5 6 and
general population.6–8 It affects one in three
adults,7 9 10 accounting 1% of general practi-
tioners’ (GPs) consultations in primary
care.11
Incidence rates range from 11.2 to 29.5
per 1000 person-years,11–14 and the reported
prevalence rates range from 4.7 to 46.7 per
1000 person-years.10 14 15 Incidence and
prevalence rates tend to increase with age,16
in women,10 16 17 in persons from lower
socioeconomic groups, and in psychologic-
ally stressed populations.18
Despite the large group of individuals
seeking for primary-care services, about 50%
of patients with shoulder pain still report per-
sistent pain after 12 months.9 16 18 19 As a
result, socioeconomic burdens are consider-
able due to extensive use of heath care ser-
vices, sickness absence, disability pension
and loss of productivity,20–24 as well as
patient’s suffering.
That is why there is a consensus in the
ﬁeld that research efforts need to be focused
on obtaining insight into which prognostic
factors play the most important roles in
Strengths and limitations of this study
▪ The inclusion of a long battery of psychological
factors evaluating their role in the prognosis of
chronic shoulder pain.
▪ The exploration of the mediating power of self-
efficacy, kinesiophobia and pain catastrophising
in chronic shoulder pain.
▪ The inclusion of self-efficacy as an outcome
measure.
▪ Some psychological factors such as pain accept-
ance and psychological distress will be not
included in this study.
▪ Another limitation could be that some psycho-
logical factors are quite broad in definition,
increasing the risk on finding conflicting evi-
dence on their relationship with outcomes.
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chronic shoulder pain (CSP), and how those factors
impact on pain and function, as this understanding is
crucial to acquire a clear comprehension of all the
process involved in CSP and to underline pain-treatment
effects in seeking to improve the poor prognosis of this
entity.
CSP is a complex syndrome, and pain chronicity often
cannot be explained (solely) by an obvious anatomic
defect or tissue damage.25 A recent review26 exposed
that the effective management of shoulder pain relies
on a detailed knowledge of peripheral pathology
(ie, adhesive capsulitis, SLAP lesion or rotator cuff tendi-
nopathy), as well as on a comprehensive understanding
of how pain can be generated, propagated and modi-
ﬁed. In this sense, there has been a growing recognition
that the degree of chronic pain is inﬂuenced by the
beliefs, attitudes and expectations of individuals.27–29
Given the importance of pain as a mechanism of sur-
vival, it is perhaps unsurprising that pain perception is
clearly inﬂuenced by conscious and unconscious
memory, cognitive and emotional functioning and con-
textual factors that are explicitly included in a biopsy-
chosocial formulation of pain.30 Inside of the
biopsychosocial understanding of chronic pain, there is
a growing interest, and acceptance in hypothesising that
the association between physical impairment, pain inten-
sity and pain-related disability is only moderate and that
psychological factors may inﬂuence the experience of
pain and its impact and hence may play a crucial role in
the maintenance of pain-related problems.27 31
Currently, some evidence has shown how psychological
factors could be associated with the prognosis of CSP.32–
34 Reilingh et al32 investigated the course and prognosis
of shoulder pain in the 6 ﬁrst months after presentation
to the GP. Predictors of a better outcome for CSP were
lower scores on pain catastrophising and higher baseline
pain intensity (explained variance 21%). Gill et al33
examined which factors are predictive of incident, recur-
rent or resolved shoulder pain in a community-based
sample from the general population. Findings showed
how recurrent shoulder pain was associated with depres-
sive symptoms. Chester et al34 aimed to identify which
baseline patient and clinical characteristics are asso-
ciated with a better outcome, 6 weeks and 6 months
after starting a course of physiotherapy for shoulder
pain. In this study, higher patient expectation of
complete recovery compared to slight improvement
because of physiotherapy and higher pain self-efﬁcacy
were associated with patient-rated outcomes.
Therefore, it seems presumable that psychological
factors could play a role in people with shoulder pain
and favour the perpetuation of CSP. Self-efﬁcacy has
been proposed to predict pain, pain behaviour, physical
functioning and disability in chronic musculoskeletal
pain.35 36 Furthermore, self-efﬁcacy is considered to be a
stronger mediator of the relationship between pain
behaviour, pain intensity and disability than psycho-
logical factors such as kinesiophobia and pain
catastrophising.37–39 However, the role of self-efﬁcacy as
an outcome measure and as mediator in CSP has not
been studied yet. Knowing and understanding which psy-
chological factors are speciﬁcally involved in the progno-
sis of CSP is challenging to facilitate clinical
decision-making and, if necessary, timely, and speciﬁc
consultation with—or referral to—other healthcare
providers.40
There are four hypotheses in the present study. First,
higher levels of psychological factors at baseline and pro-
spectively such as kinesiophobia, pain-related fear,
depression, anxiety, patient expectations of recovery and
pain catastrophising are associated with a higher level of
pain intensity, and disability, and lower level of self-
efﬁcacy. Second, pain catastrophising and/or kinesio-
phobia mediate the relationship between pain intensity
and disability, or between self-efﬁcacy and disability at
baseline. Third, changes in pain catastrophising and/or
changes in kinesiophobia mediate the relationship
between changes in pain intensity and changes in dis-
ability, or changes in self-efﬁcacy and changes in disabil-
ity after 12 month follow-ups. Fourth, self-efﬁcacy is the
strongest mediator in the relationship between pain
intensity and disability at baseline and prospectively.
Hence, the aims of the present study will be: (1) to
analyse the level of association between psychological
factors and pain-disability at baseline and prospectively
to assess their prognostic role; (2) to evaluate the associ-
ation of pain catastrophising and kinesiophobia at
baseline and prospectively in the relationship between
pain intensity and disability or between self-efﬁcacy
and disability in patients with CSP; (3) to explore the
association of self-efﬁcacy at baseline and prospectively
in the relationship between pain intensity and
disability, in comparison with kinesiophobia and pain
catastrophising.
METHODS AND ANALYSIS
Study design and setting
The present study will be a 12 month multicentre, pro-
spective, cohort study that will be carried out between
May 2016 and April 2017 in four primary-care centres
and one hospital of the province of Malaga, Spain.
Several questionnaires assessing different psychological
factors will be administrated to these participants. The
outcomes will be assessed at baseline (t1) and at 3
follow-ups times (after 3 (t2), 6 (t3) and 12 months
(t4)). Ethical approval has been obtained from Costal
del Sol Ethics Committee, Malaga, Spain (28042016).
The study will be implemented and reported in line
with the SPIRIT statement.
Participants
A consecutive sample comprised participants with CSP
will be recruited. GPs will carry out the recruitment.
Then, the research assistants who will be previously
instructed by the research team will assess the
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participants for eligibility. If the participants satisfy the
eligibility criteria, they will be invited to participate in
this study, and then they will be evaluated at baseline
and 3, 6 and 12 months’ follow-up. The inclusion cri-
teria as follows: (1) men/women aged over 18 years and
(2) participants suffering from shoulder pain (pain
intensity of 3 or more on a 0–10 numerical pain rating
scale) will be included in this study, among all these fol-
lowing shoulder pain conditions: non-speciﬁc shoulder
pain, subacromial pain syndrome, rotator cuff tendino-
pathy, adhesive capsulitis, instability without trauma,
SLAP lesion, acromioclavicular pathology and/or shoul-
der osteoarthritis. Diagnosis will be carried out by clin-
ical testing based on the recommendations of McClure
et al,41 and radiological test through MRI and/or ultra-
sound imaging; (3) duration of symptoms: more than
3 months. The exclusion criteria as follows: (1) recent
shoulder dislocation (1 year prior) and/or systemic dis-
eases such as rheumatoid arthritis, ﬁbromyalgia and/or
polymyalgia rheumatic; (2) shoulder pain considered to
be originated from the cervical region, and other
traumas, or if there is a neurological dysfunction (ie,
multiple sclerosis or stroke), osteoporosis, haemophilia
and/or cancer; (3) participants receiving shoulder
surgery; (4) participants with shoulder pain after post
fracture; and (5) inability to provide informed consent
and/or complete written questionnaires.
Procedures
Recruitment
Anonymised age and gender details will be collected for
those participants who decline to take part in the
project, to assess the external validity of the recruited
sample of participants.
Eligible participants who will be interested in the
study will be asked to provide written informed consent
to participate. Participants will then complete several
questionnaires at baseline, 3, 6 and 12 months after the
beginning of the study.
Participant data ﬁles will be stored in numerical order
and in a secure and accessible place and manner.
Participant ﬁles will be maintained in storage for a
period of 3 years after completion of the study.
Outcomes measures
Outcome measures and some of the potential prognostic
factors will be measured at baseline and prospectively, with
the aim of observing possible associations between poten-
tial prognostic factors and pain disability, and self-efﬁcacy
at baseline, and prospectively to assess their prognostic
role, and if some of them appear as confounding factors.
Primary outcome
Pain and function
1. The Shoulder Pain and Disability Index (SPADI) is a
self-administered index consisting of 13 items divided
into two subscales: pain and disability.42 It grades a
normal shoulder as 0 and maximally affected as 130,
and an 11-point numerical pain rating scale with 0 as
normal and 10 as maximal pain.
Secondary outcome
Self-efficacy
2. Pain Self-Efﬁcacy Questionnaire (PSEQ) contains 10
questions that will measure the patient’s conﬁdence in
performing certain activities despite pain. Items are
scored on a scale from 0 to 6, with a maximum pos-
sible score of 60 points. Lower scores indicate less
self-efﬁcacy.43
Potential prognostic factors
Psychological factors will be assessed through four ques-
tionnaires at baseline, 3, 6 and 12 months follow-up.
Kinesiophobia, pain-related fear, pain catastrophising,
anxiety, depression and patient expectations of recovery
1. The Fear-avoidance Components Scale (FACS) is a
new patient-reported measure designed to evaluate
pain-related fear and kinesiophobia in patients with
painful medical conditions. It consists of 20 items
that are scored on a 5-point scale.44
2. The Pain Catastrophising Scale (PCS) will be
included to assess catastrophic thinking about pain.
It consists of 13 items describing different thoughts
and feelings that individuals may have when experi-
encing pain. Items are scored on a 5-point scale. A
general score and scores on three subscales (ie, help-
lessness, magniﬁcation and rumination) will be
obtained; higher scores indicate more severe cata-
strophic thoughts about pain.45
3. The Hospital Anxiety and Depression Scale (HADS)
is a 14-item scale designed to detect anxiety and
depression, independent of somatic symptoms. It
consists of two 7-item subscales measuring depression
(HADS-D) and anxiety (HADS-A). It uses a 4-point
response scale that ranges from 0 (absence of symp-
toms) to 3 (maximum symptoms), with possible
scores for each subscale ranging from 0 to 21.46
Higher scores indicate higher levels of disorder. The
HADS has been widely used as a screening instru-
ment for the detection of comorbid depressive and
anxiety disorders in patients with musculoskeletal dis-
orders.47–49
4. Patient expectations of recovery will be measured by
asking the participants to rate the likelihood that
they would resume some form of recovery at 3, 6 and
12 months’ follow-up (“How likely is it that within the
next 3 months you will have resumed some form of
recovery?”). Participants will indicate their response
on a scale with the end points (0%) not at all likely
to (100%) extremely likely.50
Other potential prognostic factors
1. Side of shoulder problem (right, left and both) will
be coded into three levels: (i) right; (ii) left and
(iii) both.
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2. Shoulder dominance (right, left and ambidexterity)
will be coded into three levels: (i) right; (ii) left and
(iii) ambidexterity.
3. History of previous shoulder problems will be mea-
sured with a yes/no question.
4. Current treatment will be evaluated through a
checklist divided in ﬁve groups: (i) no treatment;
(ii) pharmacological treatment; (iii) injections; (iv)
physical therapy and (v) other treatments (massage,
reﬂexology, acupuncture).
5. Being convinced of this pathology will be measured
with a yes/no question.
6. Active shoulder ROM-free of pain will be measured
with a manual inclinometer placed in the affected
shoulder.
7. Comorbidities will be tested with the
Self-Administered Comorbidity Questionnaire
(SCQ).51 Patients will be asked if they had one or
more medical conditions (from a list of 15 diagno-
ses). If they gave a positive response, they will be
asked whether the condition limited their activity.
8. Recurrence of shoulder problem was dichotomised
to those patients who had a recurrent episode
within the past 12 weeks and those who had a recur-
rent episode more than 12 weeks. With a simple
answer: yes/no.
9. The Numerical Rating Scale (NRS) was used to
assess each patient’s pain intensity at baseline and
follow-ups. The NRS scores range from 0 to 10, with
0 representing no pain and 10 representing the
worst pain imaginable. The NRS has been shown to
have good same-day test–retest reliability.52
10. Work status will be coded into ﬁve categories of
work: (i) unemployment; (ii) sick leave; (iii) retire-
ment; (iv) housewife and (v) active worker.
11. Work absenteeism will be measured by the following
sentence: how many days (if any) within the previ-
ous 4 weeks’ care workers had not attended work
due to feeling ill and unﬁt for work. Respondents
answered by number of days. Numbers were then
grouped into three categories (0=0 days, 1=1–2 days,
2=3 or more days).53
12. Work performance will be measured by the Word
Health Organization Health and Work Performance
Questionnaire (HPQ) through the following sen-
tence: How would you rate your overall job perform-
ance on the days you worked during the past
4 weeks (28 days)?; responses used a scale ranging
from 0 to 10, with higher scores indicating higher
work performance in the previous 4 weeks.54
13. Educational level will be coded into ﬁve educational
levels: (i) university/college ≥4 years; (ii) univer-
sity/college 4 years; (iii) upper secondary; (iv) elem-
entary secondary and (v) no studies.55
14. Gender, age, height and weight will be reported by
self-reported questionnaire.
The summary of potential prognostic factors and
outcome measures is presented in table 1.
Sample size estimation
To contrast the null hypothesis that six potential prog-
nostic factors (kinesiophobia, pain-related fear, pain cat-
astrophising, anxiety-depression, age and gender)
included in the estimation does not explain the primary
outcome, ANOVA-test in a multiple linear regression
model will be used, considering a signiﬁcance level of
0.05, and a statistical power of 0.9, assuming that one
variable (anxiety-depression34) provides a coefﬁcient of
determination of 0.31, and for a higher coefﬁcient of
0.36, a sample of 230 patients will be needed. Assuming
an expected drop-out rate of 25%, a total number of 307
patients will be needed.
Statistical analysis
Data set will be carried out using SPSS for Windows
(V.22; SPSS, Chicago, IL). There will be four measure-
ments in the study, T1=at baseline, T2=3 months,
T3=6 months, T4=12 months’ follow-up. Kolmogorov–
Smirnov test will be used to analyse the normal distribu-
tion of the variables (p>0.05). Continuous variables will
be presented through centrality measures (mean,
median), and dispersion (SD and IQR), and categorical
variables through frequencies and percentages. Rank
sums, Wilcoxon signed Rank test, Mann–Whitney U test
and Friedman’s test will be used depending on the com-
parisons to be made, in case of non-normal distribution
of variables. For the identiﬁcation of potential prognos-
tic factors, the psychological variables (kinesiophobia,
pain-related fear, pain catastrophising, anxiety, depres-
sion and patient expectations of recovery) and sociode-
mographic characteristics (age, gender, height, weight,
shoulder problems, work status, work absenteeism, work
performance, intensity of pain, active shoulder
ROM-free of pain, educational level, treatments received
and comorbidities) will be introduced as predictors in a
multiple linear regression analysis, taking SPADI as con-
tinuous dependent variable.
Finally, analysis through COX regression will be con-
ducted to determine the HRs of the aforementioned
factors with the presence of pain and disability (using
SPADI values to determine this state), through propor-
tional hazard models. A p-value<0.05 will be considered
statistically signiﬁcant.
Data collection and management
To ensure accurate, complete and reliable data, all study-
related information will be stored securely at the study
site. All participant information will be stored in locked
ﬁle cabinets in areas with limited access. A coded ID
number will identify reports, data collection, process
and administrative forms only to maintain participant
conﬁdentiality.
Modification of the protocol
Any modiﬁcations to the protocol that may affect the
conduct of the study, potential beneﬁt of the patient or
may affect patient safety, including changes of study
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Table 1 Overview of measurement instruments and time of assessment
Construct Type
Staff
member
Baseline
(T1)
3 months
(T2)
6 months
(T3)
12 months
(T4)
Outcome measures
Pain and function SPADI Interviewer X X X X
Self-efficacy PSEQ Interviewer X X X X
Shoulder problems
Side of shoulder problem (i) right; (ii) left; (iii) both. Self-reported
questionnaire
Interviewer X
Shoulder dominance (i) right; (ii) left; (iii) ambidexterity Self-reported
questionnaire
Interviewer X
History of previous shoulder problems Self-reported
questionnaire
(yes/no)
Interviewer X
What modality of treatment? ((i) no treatment; (ii) pharmacological
treatment; (iii) injections; (iv) physical therapy; (v) other treatments
(massage, reflexology, acupuncture)
Self-reported
questionnaire
Interviewer X X X X
Have you been convinced of this pathology? Self-reported
questionnaire
(yes/no)
Interviewer X X X X
Potential prognostic factors
Pain-related fear and kinesiophobia FACS Interviewer X X X X
Pain catastrophising PSC Interviewer X X X X
Active shoulder ROM-free of pain Manual Inclinometer Interviewer X X X X
Anxiety and depression HADS Interviewer X X X X
Patient expectations of recovery Self-reported question
(0–100)
Interviewer X X X X
Comorbidities SCQ Interviewer X X X X
Recurrence of shoulder pain Self-reported
questionnaire
(yes/no)
Interviewer X
Intensity of pain NRS Interviewer X X X X
Work status ((i) unemployment; (ii) sick leave; (iii) retirement; (iv)
housewife; (v) active worker)
Self-reported
questionnaire
Interviewer X X X X
Work absenteeism Self-reported
questionnaire
Interviewer X X X X
Work performance Question obtaining
of HPQ
Interviewer X X X X
Age, gender Self-reported
questionnaire
Interviewer X
Height, weight Self-reported
questionnaire
Interviewer X
Educational level: (i) university/college ≥4 years; (ii) university/college
4 years; (iii) upper secondary; (iv) elementary secondary; (v) no studies
Self-reported
questionnaire
Interviewer X
FACS, Fear-avoidance Components Scale; HADS, Hospital Anxiety and Depression Scale; NRS, Numerical Rating Scale; PCS, Pain Catastrophising Scale; PSEQ, Pain Self-Efficacy
Questionnaire; SCQ, Self-Administered Comorbidity Questionnaire.
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objectives, study design, patient population, sample sizes
and study procedures, or signiﬁcant administrative
aspects will require a formal amendment to the
protocol.
Such amendment will be agreed on by this research
group and approved by Costa del Sol Ethics Committee,
Malaga, Spain, prior to implementation and notiﬁed to
the health authorities in accordance with local
regulations.
Dissemination
The trial is registered in Clinicaltrials.gov:
NCT02738372.
The results of the study will be disseminated at several
research conferences and as published articles in peer-
reviewed journals.
DISCUSSION
The present study will be the ﬁrst study analysing the
role of a long battery of psychological factors (pain-
related fear, kinesiophobia, anxiety, depression, patient
expectations of recovery and pain catastrophising) in the
prognosis of CSP. Previous studies32–34 56 57 have evalu-
ated the inﬂuence of several psychological factors on the
prognosis of CSP. Macfarlane et al56 showed how higher
levels of psychological distress predicted perpetuation of
CSP. Badcock et al57 reported association between dis-
ability and psychological distress after controlling for
possible confounders. Reilingh et al32 exposed how
higher levels of pain catastrophising predicted recur-
rence of symptoms in CSP. Gill et al33 showed how recur-
rent shoulder pain was associated with depressive
symptoms. Chester et al34 reported how higher patient
expectation of complete recovery compared to slight
improvement as a result of physiotherapy and higher
pain self-efﬁcacy were associated with patient-rated out-
comes. These previous studies support the necessity of
carrying out the present study, but also the inclusion of
several psychological factors, which have not been
already evaluated on the prognosis of CSP, such as pain-
related fear, kinesiophobia and anxiety, justifying the
development of this cohort study, because it seems pre-
sumable that psychological factors may play an essential
role along with biomedical and/or biomechanical
factors in the perpetuation of chronicity in patients with
CSP. Besides that, this will be the ﬁrst study evaluating
self-efﬁcacy as an outcome measure in shoulder region.
Previous studies have explored how psychological factors
inﬂuence self-efﬁcacy in chronic musculoskeletal condi-
tions,58 and how several therapeutic strategies could
improve this psychological construct.59 60 Therefore, the
inclusion of self-efﬁcacy as an outcome in this study
could be reasonable, because this construct is based on
how a person’s perceived conﬁdence in the ability of
successfully carrying out daily and/or work activities or
behaviour despite the pain,61 and people with CSP
usually have to do many tasks that implicate the
movement of their shoulders. That is why, detecting pos-
sible factors which contribute to improve or reducing
effects of self-efﬁcacy in people with CSP may give rise
to beneﬁts for this population.
Strengths and weaknesses of the study
The strengths of this study will include a long battery of
psychological factors evaluating their role in the progno-
sis of CSP, the exploration of the mediating power of
self-efﬁcacy, kinesiophobia and pain catastrophising in
CSP, the inclusion of self-efﬁcacy as an outcome
measure and the use of the SPIRIT checklist to give
more quality to the study. The limitations associated with
this study must be acknowledged when interpreting the
results. First, information bias could be an important
limitation of this study. Some participants may have pro-
blems to deal with the questionnaires and remember
any situation associated with their pain and disability at
3, 6 and 12 months’ follow-up. Even so, some partici-
pants might be more likely to deny participation or
abort follow-up. However, adding a drop-out rate of 20%
in sample size calculation should alleviate this risk.
Furthermore, some psychological factors such as pain
acceptance and psychological distress will be not
included in this study, because it takes too much time to
carry out all the self-reported questionnaires, and parti-
cipants may not respond clearly. Another limitation
could be that some psychological factors are quite broad
in deﬁnition, increasing the risk on ﬁnding conﬂicting
evidence on their relationship with outcomes.
Clinical and research implications of study findings
The early identiﬁcation of which psychological factors
have higher predictive value in people with CSP may
assist clinicians in decision-making, and timely and spe-
ciﬁc consultations with—or referral to—other healthcare
providers, and to researchers in exploring which psycho-
logical factors could be the most predictive power in
shoulder region, giving rise to the possibility to steer
treatments. That is why clinicians should be encouraged
to identify patients with CSP who show psychological
symptoms in the preliminary assessment, as this
approach might increase the possibility to consider
other therapeutic interventions rather than physical
therapies for CSP, for example, pain neuroscience
education.
Future research
Further studies analysing prospectively the inﬂuence of
psychological factors on the prognosis of CSP including
several factors such as pain acceptance, psychological
distress and/or coping with pain are needed. As CSP is a
complex multifactorial condition, future investigations
should consider the combination, and interaction of a
cluster of factors to increase their predictive value, and
to determine the importance of each factor. Even
though the effect caused by psychological factors on the
prognosis of CSP could be relevant, further research
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evaluating the effects of these factors on the prognosis
of CSP, and the possible mediating power of these
factors in this entity, as well as their clinical usefulness is
required.
CONCLUSION
Despite the neuroanatomical and biomechanical basis of
shoulder pain is interminable and not completely
understood, this prospective cohort study may contrib-
ute to a new vision about the role played by pain-related
fear, kinesiophobia, anxiety, depression and pain cata-
strophising in the prognosis of CSP, and how self-efﬁcacy,
kinesiophobia and pain catastrophising mediate the rela-
tionship between symptoms, increasing the body of
knowledge in this ﬁeld.
Current study status
The recruitment of patients began in August 2016.
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